CLC Policy Issues: FDA


	Home \| Sitemap \| Contact Info

	Clinical Trials—Medicare \| Clinical Trials—Private Insurance \| Medicare Payment FDA \| Cancer Research \| Stem Cell Research \| Privacy \| Other


		CLC Recommends the Appointment of a Permanent FDA Commissioner (November 18, 2005) November 18, 2005 The President The White House Washington, D.C. 20500 Dear Mr. President: The undersigned organizations represent cancer patients, providers and researchers. We understandably place great value on the work of the Food and Drug Administration (FDA) and National Cancer Institute (NCI). The cancer community depends on NCI to provide leadership and substantial federal funding for basic, translational and clinical cancer research leading to discoveries of new cancer therapies, and on FDA as the efficient gatekeeper for approval and marketing of those products. The absence of permanent qualified leadership at the two agencies is a cause for concern to the more than 1 million patients who are diagnosed with cancer annually and the approximately 12 million people living with cancer in the United States. We urge you, Mr. President, to make appointment of a permanent FDA Commissioner and permanent NCI Director a priority for your Administration. Every day that these important positions are left in doubt runs the risk that morale at both agencies will suffer and opportunities for advances against cancer will be missed. The governance of both NCI and FDA must be securely in the hands of highly qualified leaders who can devote full and undivided attention to the vital missions entrusted to them. We hope and trust that you and your senior staff will turn your attention without delay to the matter of appointing permanent leaders for these important custodians of cancer research and treatment in the United States. Sincerely, Cancer Leadership Council American Psychosocial Oncology Society American Society of Clinical Oncology American Society for Therapeutic Radiology & Oncology C3: Colorectal Cancer Coalition Cancer Care Cancer Research and Prevention Foundation The Children's Cause for Cancer Advocacy Coalition of Cancer Cooperative Groups Fertile Hope International Myeloma Foundation Kidney Cancer Association The Leukemia & Lymphoma Society The Lung Cancer Alliance Lymphoma Research Foundation Multiple Myeloma Research Foundation National Coalition for Cancer Survivorship National Patient Advocate Foundation North American Brain Tumor Coalition Ovarian Cancer National Alliance Pancreatic Cancer Action Network The Wellness Community Y-ME National Breast Cancer Organization Back to FDA Index About CLC \| What's New \| Policy Issues \| Participants' Login Home \| Sitemap \| Contact Info Copyright © 2001-2002 Cancer Leadership Council. All rights reserved. Please send comments and suggestions to webmaster@cancerleadership.org.